HIND A. ALNAJASHI; FOZIAH ALSHAMRANI,. Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment. Journal of King Abdulaziz University: Medical Sciences, [S. l.], v. 27, n. 2, p. 33–44, 2020. DOI: 10.4197/Med.27-2.6. Disponível em: https://journals.kau.edu.sa/index.php/MedSci/article/view/883. Acesso em: 24 nov. 2024.